THE SENATE	S.B. NO.	174
TWENTY-SIXTH LEGISLATURE, 2011		S.D. 1
STATE OF HAWAII

A BILL FOR AN ACT

RELATING TO HEALTH.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

     SECTION 1.  This Act removes marijuana (cannabis) and tetrahydrocannabinols (THC), the active ingredient in marijuana, from their current classifications as schedule I controlled substances to the more appropriate schedule III controlled substances.  According to existing law, a substance is placed in schedule III if the substance has a degree of danger or probable danger less than schedules I and II controlled substances.  Schedule II controlled substances currently include heroin and opiates like oxycodone, methadone, tapentadol, fentanyl, and amphetamine and methamphetamine, all of which have been linked to deaths by overdoses.  In contrast, marijuana has not been linked to overdose deaths.  In addition, the pharmaceutical drug dronabinol also known as marinol, which contains one hundred per cent synthetic THC, is classified as a schedule III controlled substance.  This measure places marijuana and marinol in the same schedule, in recognition of the fact that medical use of marijuana is permitted in Hawaii.

     The purpose of this Act is to remove marijuana and tetrahydrocannabinols from the list of schedule I controlled substances and place them in the list of schedule III controlled substances.

     SECTION 2.  Section 329-14, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:

     "(d)  Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

     (1)  Alpha-ethyltryptamine (AET);

     (2)  2,5-dimethoxy-4-ethylamphetamine (DOET);

     (3)  2,5-dimethoxyamphetamine (2,5-DMA);

     (4)  3,4-methylenedioxy amphetamine;

     (5)  3,4-methylenedioxymethamphetamine (MDMA);

     (6)  N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy-MDA);

     (7)  3,4-methylenedioxy-N-ethylamphetamine (MDE);

     (8)  5-methoxy-3,4-methylenedioxy-amphetamine;

     (9)  4-bromo-2,5-dimethoxy-amphetamine(4-bromo-2,5-DMA);

    (10)  4-Bromo-2,5-dimethoxyphenethylamine (Nexus);

    (11)  3,4,5-trimethoxy amphetamine;

    (12)  Bufotenine;

    (13)  4-methoxyamphetamine (PMA);

    (14)  Diethyltryptamine;

    (15)  Dimethyltryptamine;

    (16)  4-methyl-2,5-dimethoxy-amphetamine;

    (17)  Gamma hydroxybutyrate (GHB) (some other names include gamma hydroxybutyric acid; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);

    (18)  Ibogaine;

    (19)  Lysergic acid diethylamide;

   [(20)  Marijuana;

(21)] (20)  Parahexyl;

   [(22)] (21)  Mescaline;

   [(23)] (22)  Peyote;

   [(24)] (23)  N-ethyl-3-piperidyl benzilate;

   [(25)] (24)  N-methyl-3-piperidyl benzilate;

   [(26)] (25)  Psilocybin;

   [(27)] (26)  Psilocyn;

   [(28)] (27)  1-[1-(2-Thienyl) cyclohexyl] Pyrrolidine (TCPy);

   [(29)  Tetrahydrocannabinols;

(30)] (28)  Ethylamine analog of phencyclidine (PCE);

   [(31)] (29)  Pyrrolidine analog of phencyclidine (PCPy, PHP);

   [(32)] (30)  Thiophene analog of phencyclidine (TPCP; TCP);

   [(33)] (31)  Gamma-butyrolactone, including butyrolactone; butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone; tetrahydro-2‑furanone; 1,2-butanolide; 1,4-butanolide; 4‑butanolide; gamma-hydroxybutyric acid lactone; 3‑hydroxybutyric acid lactone and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number 96‑48-0 when any such substance is intended for human ingestion;

   [(34)] (32)  1,4 butanediol, including butanediol; butane-1,4‑diol; 1,4- butylenes glycol; butylene glycol; 1,4‑dihydroxybutane; 1,4- tetramethylene glycol; tetramethylene glycol; tetramethylene 1,4- diol with Chemical Abstract Service number 110-63-4 when any such substance is intended for human ingestion;

   [(35)] (33)  2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C‑T-7), its optical isomers, salts, and salts of isomers;

   [(36)] (34)  N-benzylpiperazine (BZP; 1-benzylpiperazine) its optical isomers, salts, and salts of isomers;

   ((37)] (35)  1-(3-trifluoromethylphenyl)piperazine (TFMPP), its optical isomers, salts, and salts of isomers;

   [(38)] (36)  Alpha-methyltryptamine (AMT), its isomers, salts, and salts of isomers;

   [(39)] (37)  5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts, and salts of isomers;

   [(40)] (38)  Salvia divinorum;

   [(41)] (39)  Salvinorin A; and

   [(42)] (40)  Divinorin A."

     SECTION 3.  Section 329-18, Hawaii Revised Statutes, is amended by amending subsection (h) to read as follows:

     "(h)  Hallucinogenic substances, unless listed in another schedule, shall include Dronabinol (synthetic), in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product[.], marijuana, and tetrahydrocannabinols."

     SECTION 4.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 5.  This Act shall take effect on July 1, 2050.

Report Title:

Controlled Substances; Marijuana

Description:

Removes marijuana and tetrahydrocannabinols from the schedule I controlled substances list and places them in the schedule III controlled substances list.  Effective 7/1/2050.  (SD1)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.